Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,298 | 193 | 97.7% |
| Education | $102.51 | 4 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,410 | 70 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $585.59 | 36 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $389.27 | 20 | $0 (2024) |
| Ardelyx, Inc. | $365.07 | 12 | $0 (2024) |
| GENZYME CORPORATION | $298.82 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $261.57 | 12 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $137.14 | 2 | $0 (2024) |
| Medtronic, Inc. | $134.59 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $109.54 | 5 | $0 (2024) |
| Celgene Corporation | $106.54 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,323 | 56 | ABBVIE INC. ($293.69) |
| 2023 | $1,742 | 75 | ABBVIE INC. ($558.08) |
| 2022 | $1,335 | 66 | ABBVIE INC. ($558.12) |
All Payment Transactions
197 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: Gastroenterology | ||||||
| 12/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Medtronic, Inc. | PILLCAM (Device) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Capsule Endoscopy | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $27.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.87 | General |
| Category: GI | ||||||
| 09/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Gastroenterology | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: Gastroenterology | ||||||
| 08/26/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.22 | General |
| Category: GI | ||||||
| 08/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Gastroenterology | ||||||
| 08/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $25.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 289 | 331 | $96,994 | $26,468 |
| 2022 | 3 | 92 | 101 | $29,193 | $8,647 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 155 | $39,564 | $12,084 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 108 | 108 | $42,374 | $10,094 | 23.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 41 | $7,031 | $2,141 | 30.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $5,266 | $1,260 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $2,760 | $890.39 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $16,479 | $4,702 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 31 | $7,913 | $2,666 | 33.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 28 | $4,801 | $1,279 | 26.6% |
About Casey Forman
Casey Forman is a Physician Assistant healthcare provider based in Villa Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/06/2021. The National Provider Identifier (NPI) number assigned to this provider is 1750055307.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Casey Forman has received a total of $4,401 in payments from pharmaceutical and medical device companies, with $1,323 received in 2024. These payments were reported across 197 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,298).
As a Medicare-enrolled provider, Forman has provided services to 381 Medicare beneficiaries, totaling 432 services with total Medicare billing of $35,115. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Villa Park, IL
- Active Since 08/06/2021
- Last Updated 03/16/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750055307
Products in Payments
- SKYRIZI (Biological) $506.48
- RINVOQ (Biological) $430.56
- ENTYVIO (Biological) $372.71
- IBSRELA (Drug) $365.07
- XIFAXAN (Drug) $359.39
- LINZESS (Drug) $340.84
- DUPIXENT (Biological) $298.82
- TRULANCE (Drug) $226.20
- STELARA (Biological) $220.19
- VOQUEZNA (Drug) $137.14
- ENDOFLIP (Device) $112.56
- DIFICID (Drug) $109.54
- ZEPOSIA (Drug) $106.54
- ZYMFENTRA (Biological) $102.51
- Linzess (Drug) $83.20
- ZENPEP (Drug) $67.73
- OCALIVA (Drug) $51.00
- CREON (Drug) $50.14
- VIBERZI (Drug) $48.17
- SUCRAID (Drug) $47.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.